Back
Stantec, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
47
STN
Stantec, Inc.
Last Price:
$94.16
Seasonality Move:
26%
Sell
24
NVO
Novo Nordisk A/S
Last Price:
$48.11
Seasonality Move:
4.04%
Sell
47
Stantec, Inc. (STN)
is a Sell
Is Stantec, Inc. a Buy, Sell or Hold?
-
The current Stantec, Inc. [STN] share price is $94.20. The Score for STN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
STN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $48.09. The Score for NVO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STN Stock Price Chart
What is Stantec, Inc.'s stock price today?
-
The Stantec, Inc. share price today is $94.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STN is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $48.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
STN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.55 | Buy |
| Relative Strength Index (14 RSI): | 39.85 | Sell |
| Chaikin Money Flow: | 324402 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.93 - 98.01) | Sell |
| Bollinger Bands (100): | (99.54 - 112.4) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 46.95 | Sell |
| Chaikin Money Flow: | -7995446 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.92 - 49.34) | Sell |
| Bollinger Bands (100): | (48.13 - 56.93) | Sell |
STN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.95 | Buy |
| 20-day SMA: | 94.74 | Sell |
| 50-day SMA: | 102.94 | Sell |
| 200-day SMA: | 101.45 | Sell |
| 8-day EMA: | 49.41 | Buy |
| 20-day EMA: | 24.18 | Buy |
| 50-day EMA: | 10.54 | Buy |
| 200-day EMA: | 2.75 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.04 | Sell |
| 20-day SMA: | 48.12 | Sell |
| 50-day SMA: | 50 | Sell |
| 200-day SMA: | 60.88 | Sell |
| 8-day EMA: | 48.42 | Sell |
| 20-day EMA: | 48.52 | Sell |
| 50-day EMA: | 50.22 | Sell |
| 200-day EMA: | 63.1 | Sell |
Stantec, Inc. Earnings Growth & STN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.57 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.16 per share.
Stantec, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||